Stocks and Investing Stocks and Investing
Mon, May 1, 2023

Yatin Suneja Upgraded (BIIB) to Strong Buy and Increased Target to $350 on, May 1st, 2023


Published on 2024-10-28 03:13:10 - WOPRAI, Yatin Suneja
  Print publication without navigation


Yatin Suneja of Guggenheim, Upgraded "Biogen Inc." (BIIB) to Strong Buy and Increased Target from $270 to $350 on, May 1st, 2023.

Yatin has made no other calls on BIIB in the last 4 months.



There are 15 other peers that have a rating on BIIB. Out of the 15 peers that are also analyzing BIIB, 4 agree with Yatin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $302 on, Wednesday, April 26th, 2023
  • Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $263 on, Wednesday, April 26th, 2023
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $282 on, Wednesday, April 26th, 2023
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $300 on, Friday, April 21st, 2023


These are the ratings of the 11 analyists that currently disagree with Yatin


  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $321 on, Wednesday, April 26th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Wednesday, April 26th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $340 on, Wednesday, April 26th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Wednesday, April 26th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $371 on, Wednesday, April 26th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $330 on, Wednesday, April 26th, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $320 on, Monday, April 17th, 2023
  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $346 on, Monday, April 17th, 2023
  • Matthew Korn of "Morgan Stanley" Maintained at Buy with Decreased Target to $349 on, Wednesday, April 12th, 2023
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $315 on, Thursday, February 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $340 on, Thursday, February 16th, 2023

Contributing Sources